Wells Fargo raised the firm’s price target on Integer to $103 from $100 and keeps an Equal Weight rating on the shares. While Integer continues to benefit from pulsed field ablation and structural heart in 2024, Wells continues to believe tough year over year comps limit potential upside to guidance, the analyst tells investors in a research note.